...
首页> 外文期刊>Powder Technology: An International Journal on the Science and Technology of Wet and Dry Particulate Systems >Novel disintegrating microcrystalline cellulose pellets with improved drug dissolution performance
【24h】

Novel disintegrating microcrystalline cellulose pellets with improved drug dissolution performance

机译:具有改善的药物溶解性能的新型崩解微晶纤维素颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

Pellets obtained from extrusion/spheronization generally do not disintegrate, especially those prepared from microcrystalline cellulose (MCC). The aim of present study was to develop fast disintegrating MCC pellets in order to improve drug dissolution. Formulations containing a model drug having a low aqueous solubility (i.e., indo-methacin) and MCC were prepared with or without the addition of polyethylene glycol 400 (PEG 400; 0-10% w/w), polysorbate 80 (0-10% w/w) and croscarmellose sodium (CCS; 0-10% w/w) using a basket extruder and spheronizer. Ethanolic solution (15% v/v) was used as a granulating liquid. AH formulations of pellets showed acceptable yield, aspect ratio and mechanical strength. The MCC pellets did not disintegrate and showed slow drug dissolution while the formulations with PEG 400 and/or polysorbate 80 disintegrated within 90 s and their drug dissolution was increased. The incorporation of CCS allowed the pellets to explode and disintegrate into two smaller pieces within 5 s after contact to an aqueous medium. The increased amount of CCS (from 2 to 10% w/w) insignificantly decreased disintegration time or increased drug dissolution. A slight difference in drug dissolution between freshly prepared pellets and pellets stored for 18 months may be due to the instability of drug in liquisolid environment The results from this study suggest that the disintegrating or exploding MCC pellets could be prepared by incorporating PEG 400, polysorbate 80 and CCS, and promising for increasing dissolution of poorly water-soluble drugs.
机译:通过挤出/滚圆法制得的粒料通常不会崩解,尤其是由微晶纤维素(MCC)制得的粒料。本研究的目的是开发快速崩解的MCC药丸,以改善药物的溶出度。在添加或不添加聚乙二醇400(PEG 400; 0-10%w / w),聚山梨酸酯80(0-10%)的情况下,制备包含具有低水溶性的模型药物(即吲哚美辛)和MCC的制剂w / w)和交联羧甲基纤维素钠(CCS; 0-10%w / w),使用篮式挤出机和滚圆机。乙醇溶液(15%v / v)用作制粒液体。颗粒的AH配方显示出可接受的产率,纵横比和机械强度。 MCC颗粒未崩解并显示缓慢的药物溶解,而具有PEG 400和/或聚山梨酯80的制剂在90 s内崩解,药物溶解度增加。 CCS的加入使药丸在接触水性介质后5秒钟内爆炸并崩解成两个较小的碎片。 CCS量的增加(从2%到10%w / w)显着减少了崩解时间或增加了药物溶解。新鲜制备的药丸和储存18个月的药丸之间药物溶出度的细微差异可能是由于药物在液固环境中的不稳定性所致。本研究的结果表明,可以通过掺入PEG 400,聚山梨酯80制备崩解或爆炸的MCC药丸。和CCS,并有望增加水溶性差的药物的溶出度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号